Get the Stockscreener App
40.87
0.87%
-0.36
Pre-market:
41.28
0.41
+1.00%
Vericel Corp stock is traded at $40.87, with a volume of 532.73K.
It is down -0.87% in the last 24 hours and down -11.65% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$41.23
Open:
$40.63
24h Volume:
532.73K
Relative Volume:
1.20
Market Cap:
$2.07B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
583.86
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-0.87%
1M Performance:
-11.65%
6M Performance:
-0.75%
1Y Performance:
-6.56%
1-Day Range:
$40.31
$41.74
1-Week Range:
$39.78
$42.37
52-Week Range:
$37.76
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
40.87 | 2.07B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Wells Fargo & Company MN - Defense World
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Analyzing Vericel (NASDAQ:VCEL) and Sangamo Therapeutics (NASDAQ:SGMO) - Defense World
Envestnet Asset Management Inc. Decreases Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Alliancebernstein L.P. Sells 3,160 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (VCEL) Price Target Lowered by BTIG Ahead of Q1 MedTech Results | VCEL Stock News - GuruFocus
Vericel expects minimal impact from new tariffs - Investing.com Australia
Vericel expects minimal impact from new tariffs By Investing.com - Investing.com South Africa
Vericel CorpAnticipates Minimal Impact From New TariffsSEC Filing - marketscreener.com
Truist Financial Cuts Vericel (NASDAQ:VCEL) Price Target to $51.00 - Defense World
Truist Financial Has Lowered Expectations for Vericel (NASDAQ:VCEL) Stock Price - Defense World
Vericel Corp (VCEL): An Important Analyst Insights - stocksregister.com
Vericel Co. (NASDAQ:VCEL) Stock Position Lifted by LPL Financial LLC - Defense World
JPMorgan Chase & Co. Acquires 119,574 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel (VCEL) Price Target Cut by Truist Analyst Ahead of Q1 Re - GuruFocus
VCEL stock touches 52-week low at $38.88 amid market challenges - Investing.com
Vericel Co. (NASDAQ:VCEL) Shares Bought by JPMorgan Chase & Co. - Defense World
Vanguard Group Inc. Has $191.39 Million Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
KLP Kapitalforvaltning AS Makes New Investment in Vericel Co. (NASDAQ:VCEL) - Defense World
Sei Investments Co. Reduces Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Mosaic ImmunoEngineering (OTCMKTS:CPMV) Trading Down 19.9% – Should You Sell? - The AM Reporter
5 Best Stem Cell Companies to Invest In (April 2025) - Securities.io
Teacher Retirement System of Texas Acquires 2,948 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Envestnet Portfolio Solutions Inc. Buys Shares of 4,752 Vericel Co. (NASDAQ:VCEL) - Defense World
United-Guardian (NASDAQ:UG) Now Covered by Analysts at StockNews.com - The AM Reporter
HighTower Advisors LLC Buys 56 Shares of VeriSign, Inc. (NASDAQ:VRSN) - The AM Reporter
Alkemy Capital Investments (LON:ALK) Stock Passes Above 200 Day Moving Average – Here’s What Happened - The AM Reporter
Nuveen Arizona Quality Municipal Income Fund (NYSE:NAZ) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - The AM Reporter
Q4 EPS Estimate for Affiliated Managers Group Cut by Analyst - The AM Reporter
Q2 Earnings Forecast for MAG Silver Issued By Roth Capital - The AM Reporter
Harrow (NASDAQ:HROW) Shares Gap Up on Better-Than-Expected Earnings - The AM Reporter
Analysts Set Vericel Co. (NASDAQ:VCEL) Price Target at $62.29 - Defense World
Swiss National Bank Has $5.30 Million Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Proficio Capital Partners LLC Invests $956,000 in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Corp [VCEL] Colangelo Dominick sells 26,591 Shares for $1.23 million - Knox Daily
Charles Schwab Investment Management Inc. Buys 17,258 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
US Bancorp DE Has $130,000 Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel CEO Dominick Colangelo sells $2.45 million in stock - Investing.com
Vericel CEO Dominick Colangelo sells $2.45 million in stock By Investing.com - Investing.com Australia
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Bank of New York Mellon Corp - Defense World
Smartleaf Asset Management LLC Acquires 1,058 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Victory Capital Management Inc. - MarketBeat
Proficio Capital Partners LLC Buys New Shares in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Upgraded by StockNews.com to “Hold” Rating - Defense World
Vericel director Heidi Hagen sells $445,770 in stock By Investing.com - Investing.com South Africa
Vericel director Heidi Hagen sells $445,770 in stock - Investing.com
Vericel CFO Joseph Mara Jr. sells $445,770 in company stock - Investing.com
Vericel’s chief medical officer sells $495,300 in stock By Investing.com - Investing.com Australia
Vericel’s COO Michael Halpin sells $495,200 in stock - Investing.com
Vericel’s chief medical officer sells $495,300 in stock - Investing.com
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
4.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):